bioRxivCell BiologyPreprint
Obesity-associated lipidomic remodeling of the adrenal gland indicates an important role of the FADS2-arachidonic acid axis in adrenocortical hormone production
A. Witt, P. Mirtschink, A. Palladini, I. Mateska, H. Abdelmegeed, M. Grzybek, B. Wielockx, M. Peitzsch, U. Coskun, T. Chavakis, V. I. Alexaki
Abstract
ObjectiveAdrenocortical hormone levels increase in obesity, potentially contributing to development of obesity-associated pathologies. Here we explored whether lipidomic remodeling of the adrenal gland could mediate altered adrenocortical steroidogenesis during obesity. MethodsLipidomic analysis was performed in adrenal glands using shotgun mass spectrometry (MS), and steroid profiling of sera by liquid chromatography tandem mass spectrometry (LC-MS/MS) from lean and obese mice. Gene expression analysis was performed in adrenal glands and adrenocortical cell populations. The role of Fatty Acid Desaturase 2 (FADS2) and arachidonic acid on steroid hormone production was studied in primary adrenal gland cell cultures. ResultsAdrenal glands of obese mice displayed a distinct lipidomic profile, encompassing longer and more unsaturated storage lipids and phospholipids compared to adrenal glands of lean mice. Arachidonoyl acyl chains were abundant in the adrenal gland phospholipidome and increased upon obesity. This was accompanied by increased Fads2 expression, the rate-limiting enzyme of arachidonic acid synthesis, and enhanced plasma adrenocortical hormone levels. Inhibition of FADS2 in primary adrenal gland cell cultures abolished steroidogenesis, which was restored by arachidonic acid supplementation. ConclusionsOur data suggest that the FADS2 - arachidonic acid axis regulates adrenocortical hormone synthesis, while alterations in the content of arachidonoyl chains in the adrenal gland phopsholipidome could account for disturbed adrenocortical hormone production. HighlightsO_LIThe adrenal gland lipidome is remodeled in obesity. C_LIO_LIArachidonoyl groups are abundant in the adrenal gland phospholipidome and increase in obesity. C_LIO_LIFADS2 is highly expressed in the adrenal gland and its expression is further increased in obesity. C_LIO_LIFADS2 inhibition blunts adrenocortical steroidogenesis in primary adrenal gland cell cultures, while arachidonic acid supplementation restores it. C_LI
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Increased adipose tissue indices of androgen catabolism and aromatization in women with metabolic dysfunction
G. Ostinelli, S. Laforest, … A. Tchernof·bioRxiv·Apr 4, 2022
- Distinct adrenal gland macrophages regulate corticosteroid production
C. J. O. O'Brien, D. Sidarta-Oliveira, … A. I. Domingos·bioRxiv·Sep 5, 2023
- Anabolic lipid metabolism regulates adipose type 2 innate lymphoid cell differentiation to maintain metabolic health
M. R. Theodorou, J. Yu, … C. Wilhelm·bioRxiv·Mar 26, 2024
- HAND2 is a novel obesity-linked adipogenic transcription factor regulated by glucocorticoid signaling
Maude Giroud, Foivos‐Filippos Tsokanos, … Stephan Herzig·DiabetologiaPeer-reviewed·May 20, 2021
- Glucocorticoid-Induced Metabolic Disturbances are Exacerbated in Obesity
I. Harvey, E. J. Stephenson, … D. Bridges·bioRxiv·Jan 1, 2018
- Flattening of diurnal glucocorticoid oscillations causes Cd36 and insulin-mediated obesity
S. Tholen, K. M. Kovary, … M. N. Teruel·bioRxiv·Jan 2, 2020